LCM
CYTK icon

Landscape Capital Management’s Cytokinetics CYTK Stock Holding History

Landscape Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Buy
+24,734
New +$1.78M 0.14% 244
2024
Q3 		– Sell
-13,477
Closed -$730K – 700
2024
Q2 		$730K Buy
+13,477
New +$813K 0.06% 394
2018
Q1 		– Sell
-32,237
Closed -$263K – 511
2017
Q4 		$263K Buy
+32,237
New +$366K 0.02% 508

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Landscape Capital Management's CYTK Position: Q2 2026 in Review

Landscape Capital Management opened a new position in Cytokinetics (CYTK) in Q2 2026: 24,734 shares worth $2.11M. The stake represents 0.14% of the portfolio and ranks #244 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in CYTK as recently as Q2 2024.

Landscape Capital Management first reported a position in CYTK in Q4 2017 and has held it in 3 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Landscape Capital Management held 24,734 shares of Cytokinetics worth $2.11M as of Q2 2026.
  • Cytokinetics was a new Landscape Capital Management position in Q2 2026.
  • Cytokinetics made up 0.14% of Landscape Capital Management's portfolio in Q2 2026, its #244 holding.
  • Landscape Capital Management first reported a position in Cytokinetics in Q4 2017 and has held it in 3 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.